Home

Samlyn Capital reported a 0% stake in Corvus Pharmaceuticals CRVS · 0 sh · amendment · passive holder

Trade details

Type
5% stake report
Report
13G passive · amendment
Stake
0%
Last report
6% · filed 25/05/15
Shares held
0 sh
Class
Common Stock, par value $0.0001 per share
Event date
25/06/30
Filed
25/08/14

0% stake · fully exited

Stake
0%
Last report
6%
Since last report
−6.0pp

Corvus Pharmaceuticals trades, last 26 weeks

What else happened in Corvus Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/05/31~25/07/30

Samlyn Capital's other 5% stake reports

  • Samlyn Capital

    5% stakeVinci Compass Investments

    6% stake

    Filed 08/14

  • Samlyn Capital

    5% stakePureCycle Technologies

    4.2% stake

    Filed 05/15

  • Samlyn Capital

    5% stakePureCycle Technologies

    7.2% stake

    Filed 25/11/14

  • Samlyn Capital

    5% stakePureCycle Technologies

    8.8% stake

    Filed 25/08/14

  • Samlyn Capital

    5% stakeVinci Compass Investments

    4.8% stake

    Filed 25/05/15